Prescription Access Litigation (PAL) works to make prescription drug prices more affordable for consumers, using class action litigation and public education. PAL and its members seek to challenge illegal pricing tactics and deceptive marketing by drug companies, Pharmacy Benefit Managers, and other pharmaceutical industry players.

PAL is a national coalition of more than 130 organizations in 36 states and the District of Columbia.

PAL and its members have been involved in more than 30 class action lawsuits challenging drug industry tactics to illegally raise the price of prescription drugs. There have been 11 settlements in these cases (for a combined total of $604 million), allowing consumers and health plans who were illegally overcharged to be reimbursed and putting drug companies on notice that their illegal tactics will not go unopposed.